Phenotypically Adapted Mycobacterium tuberculosis Populations from Sputum Are Tolerant to First-Line Drugs

Author:

Turapov Obolbek1,O'Connor Benjamin D.1,Sarybaeva Asel A.1,Williams Caroline1,Patel Hemu2,Kadyrov Abdullaat S.3,Sarybaev Akpay S.4,Woltmann Gerrit5,Barer Michael R.12,Mukamolova Galina V.1

Affiliation:

1. Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom

2. Empath Pathology Services, Department of Clinical Microbiology, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom

3. National Center of Phthisiology, Akhunbaeva, Bishkek, Kyrgyzstan

4. Kyrgyz Indian Mountain Biomedical Research Center, Togolok Moldo, Bishkek, Kyrgyzstan

5. Department of Respiratory Medicine, Glenfield Hospital, Leicester, United Kingdom

Abstract

ABSTRACT Tuberculous sputum contains multiple Mycobacterium tuberculosis populations with different requirements for isolation in vitro . These include cells that form colonies on solid media (plateable M. tuberculosis ), cells requiring standard liquid medium for growth (nonplateable M. tuberculosis ), and cells requiring supplementation of liquid medium with culture supernatant (SN) for growth (SN-dependent M. tuberculosis ). Here, we describe protocols for the cryopreservation and direct assessment of antimicrobial tolerance of these M. tuberculosis populations within sputum. Our results show that first-line drugs achieved only modest bactericidal effects on all three populations over 7 days (1 to 2.5 log 10 reductions), and SN-dependent M. tuberculosis was more tolerant to streptomycin and isoniazid than the plateable and nonplateable M. tuberculosis strains. Susceptibility of plateable M. tuberculosis to bactericidal drugs was significantly increased after passage in vitro ; thus, tolerance observed in the sputum samples from the population groups was likely associated with mycobacterial adaptation to the host environment at some time prior to expectoration. Our findings support the use of a simple ex vivo system for testing drug efficacies against mycobacteria that have phenotypically adapted during tuberculosis infection.

Funder

European Commission

Biotechnology and Biological Sciences Research Council

Schlumberger Foundation

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3